FindMyKOL
Clinical trialNCT00956332UnknownPhase 1/PHASE2Interventional

Safety Study of MultiGeneAngio in Patients With Chronic Critical Limb Ischemia

SponsorMultiGene Vascular Systems Ltd.Enrollment28Critical Limb IschemiaPeripheral Arterial DiseasePeripheral Vascular Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to evaluate the safety and activity of two doses of MultiGeneAngio, a cell therapy product produced from the patient's own cells, as potential treatment for patients with chronic critical limb ischemia.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Israel
  • Barzilai Medical Center

    Ashkelon, Israel

  • Soroka Medical Center

    Beersheba, Israel

  • Rambam Medical Center

    Haifa, Israel

  • Hadassah University Hospital, Ein Kerem

    Jerusalem, Israel

  • Shaare Zedek Medical Center

    Jerusalem, Israel

  • Kaplan Medical Center

    Rehovot, Israel

  • Chaim Sheba Medical Center

    Tel Litwinsky, Israel

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

MultiGeneAngio
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2010
Primary completion
31 Aug 2011
Completion
31 May 2026
Last update posted
5 Mar 2015
Registered enrollment
28
Registry id
NCT00956332

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.